Navigation Links
Researchers Identify Liver Cancer Risk Factors
Date:1/6/2012

FRIDAY, Jan. 6 (HealthDay News) -- Two new studies from the Mayo Clinic find that hepatitis C infection and obesity could be to blame for a surge in liver cancer cases, which have tripled over the last 30 years.

Late-stage hepatocellular carcinoma (HCC), or liver cancer, has only a 10 percent to 12 percent five-year survival rate, according to figures in a Mayo news release. The researchers say their findings could help doctors diagnose the disease earlier and save lives.

Both studies appear in the January issue of Mayo Clinic Proceedings

"The studies illuminate the importance of identifying people with risk factors in certain populations to help catch the disease in its early, treatable stages," said Dr. W. Ray Kim, a gastroenterology and hepatology specialist and principal investigator of one study, in the release.

The researchers examined several decades of medical information from the Rochester Epidemiology Project -- a national database on inpatient and outpatient care. Although the U.S. National Cancer Institute estimates the rate of HCC is 5.1 cases per 100,000 people, the new study found a higher rate of 6.9 per 100,000.

The researchers also found that hepatitis C is a risk factor for HCC. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Kim said. "We're now seeing cancer patients in their 50s and 60s who contracted hepatitis C 30 years ago and didn't even know they were infected."

The study also showed that 11 percent of HCC cases were linked to obesity, particularly fatty liver disease. "It's a small percentage of cases overall," Kim noted. "But with the nationwide obesity epidemic, we believe the rates of liver cancer may dramatically increase in the foreseeable future."

In a separate study, the researchers examined Somalis living in the United States, since Somalia is known to have a high rate of hepatitis B, another risk factor for HCC. The
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
2. Potential Herpes Vaccine Disappoints Researchers
3. Fibroblasts contribute to melanoma tumor growth, say Moffitt Cancer Center researchers
4. Researchers discover protein that may represent new target for treating type 1 diabetes
5. BUSM researchers identify novel compound to halt virus replication
6. BINGO! game helps researchers study perception deficits
7. Researchers create a healthier cigarette
8. Cleveland Clinic researchers honored for contributions to science
9. UK researchers present findings from Kentucky breast cancer patients with disease relapse
10. Pitt researchers propose new model to design better flu shots
11. UTHealth researchers link multiple sclerosis to different area of brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Identify Liver Cancer Risk Factors
(Date:5/20/2013)... HealthEconomics.Com , the global leader ... present a new breakthrough in digital marketing and communications ... the reach of traditional, real-world trade shows and conferences ... feel, and benefits of a physical trade show, but ... hours a day, seven days a week, and three ...
(Date:5/20/2013)... that improved health care and significant reductions in drug ... relationship between physicians and drug company representatives who promote ... , This system, which has been in place for ... up to date on new medications, and always provided ... on the newest drugs, as well as other supplies ...
(Date:5/20/2013)... Las Vegas, NV (PRWEB) May 20, 2013 ... Health IT to improve the exchange of healthcare information, ... the creation of the WEDI ICD-10 State Collaborative ... organizations and their members in order to increase efficiencies ... ICD-10 compliance. , The goal of the new initiative ...
(Date:5/20/2013)... Irving, Texas (PRWEB) May 20, 2013 ... and Phytel, the leader in automated, provider-led population ... health systems to effect change and successfully pursue ... of advisory services and technology to accelerate the ... of the VHA IMPERATIVTM performance improvement suite of ...
(Date:5/20/2013)... May 20, 2013 The Multiple System ... the launch of its new Multiple System Atrophy ... few years, The MSA Coalition’s grass roots fundraising has ... mission beyond patient/caregiver support to now include education, advocacy ... all donations received by The Coalition go directly into ...
Breaking Medicine News(10 mins):Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 3Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5
... , FRIDAY, April 15 (HealthDay News) -- Teens who ... for traffic crashes, a new study finds. But starting ... attention and reduce impulsiveness, another study finds. In 2008, ... Virginia Beach, Va., was about 41 percent higher than for ...
... HealthDay Reporter , THURSDAY, April 14 (HealthDay News) ... an artificial pancreas for the management of type 1 diabetes, ... sugar control and reduce the risk of dangerous low blood ... that the overall time that plasma glucose levels were in ...
... A comprehensive investigation of brain tissue donated to the ... tissue donation program, determined that one-third of the brain ... from the California State Department of Developmental Services revealed ... with both autism and epilepsy than for individuals with ...
... , THURSDAY, April 14 (HealthDay News) -- Kidney ... the new organ can develop accelerated narrowing of the ... lead to organ rejection. That,s the finding of ... biopsies from 99 kidney transplant patients -- 40 with ...
... calls are a common drain on the manpower and ... that identified Baltimore City,s top 911 callers and coupled ... cutting the number of such calls while helping callers ... conceived and implemented by the non-profit agency Baltimore HealthCare ...
... the risks and benefits of a medical intervention is not ... according to an article in the Hastings Center Report ... to disclose quantitative data to patients to help them make ... determine the best way to provide information to patients. ...
Cached Medicine News:Health News:Early School Start Tied to More Teen Crashes: Study 2Health News:Latest Artificial Pancreas Trials Reduce Risk of Low Blood Sugar 2Health News:Latest Artificial Pancreas Trials Reduce Risk of Low Blood Sugar 3Health News:Mortality rate is increased in persons with autism who also have epilepsy 2Health News:Targeting top 911 callers can trim cost, improve patient care 2Health News:Targeting top 911 callers can trim cost, improve patient care 3Health News:Too Much Information? Risk-benefit data does not always lead to informed decision-making 2Health News:Too Much Information? Risk-benefit data does not always lead to informed decision-making 3
(Date:5/20/2013)... , Kalifornien, 20. Mai 2013 ... das Unternehmen die CE-Kennzeichnung für die SL-Produktfamilie ... von Aneurysmen erhalten hat. Das Unternehmen hat ... mit der kontrollierten Einführung dieser neuen Modelle ... SL-Produktfamilie auch ein verbessertes Handling, das es ...
(Date:5/20/2013)... DIEGO , May 20, 2013 Enrollment ... Elcelyx Therapeutics, Phase 2b dose-finding clinical trial of product ... metformin, the foundational treatment for Type 2 diabetes. Elcelyx ... multicenter U.S. program in June. Results of the trial,s ... expected in late summer, and the read-out for long-term ...
(Date:5/20/2013)... , May 20, 2013  AbbVie (NYSE: ... of a Phase 3 clinical study called SONAR ... the effects of the investigational compound atrasentan - when ... kidney disease in patients with stage 2 to ... diabetes.  SONAR is a large, multinational, double-blind, placebo-controlled ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
... NATICK, Mass., Jan. 4, 2011 Boston Scientific Corporation ... of its acquisition of Sadra Medical, Inc. of Los ... announced on November 19, 2010.  Under the terms of ... the remaining 86 percent of Sadra Medical,s equity not ...
... and Company) (NYSE: BDX ), a leading global medical ... Annual J. P. Morgan Healthcare Conference on Monday, January 10, 2011, ... BD,s presentation can be accessed from the BD corporate website at ... January 17, 2011.   About BDBD is ...
Cached Medicine Technology:Boston Scientific Completes Acquisition of Sadra Medical 2Boston Scientific Completes Acquisition of Sadra Medical 3Boston Scientific Completes Acquisition of Sadra Medical 4
... Autotransfusion System processes blood collected from ... red blood cells for return to ... This is achieved with only one ... bowl design, coupled with sophisticated software, ...
The Wixson Hip Positioner is used for stable positioning of a patient during total hip and revision surgery. It is designed to be placed on top of the operating table....
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
... VersaNail System is a complete system of ... use with TTC fusion surgery. The system ... and integrates clinical research and engineering with ... every patient is different, and because the ...
Medicine Products: